Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Soliton Inc (SOLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 249,018
  • Shares Outstanding, K 14,965
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,310 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.01 +231.80%
on 05/23/19
29.00 -42.62%
on 05/29/19
+9.32 (+127.32%)
since 05/17/19
3-Month
5.01 +231.80%
on 05/23/19
29.00 -42.62%
on 05/29/19
+10.17 (+157.19%)
since 03/15/19

Most Recent Stories

More News
Soliton to be Added to the Russell 2000 and 3000 Indexes on June 28, 2019

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 16.64 (+16.36%)
Soliton Announces $9.45 Million Private Placement

Soliton, Inc. (NASDAQ: SOLY), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"),...

SOLY : 16.64 (+16.36%)
Soliton Announces Long-Term Cellulite Trial Results to be Presented at The Aesthetics Show on July 11-14, 2019

Soliton, Inc. (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer...

SOLY : 16.64 (+16.36%)
Biotech Brief: Atopic Dermatitis (Eczema) Revenues Projected to Exceed $6 Billion by 2022

Recent reports by industry specialists show that the Atopic Dermatitis Drugs Market Size Worth $6.41 Billion By 2022, exhibiting a CAGR of 6.6% during the forecast period. This is an increase from the...

HOTH : 6.80 (+3.82%)
PRVB : 11.36 (-3.07%)
CVM : 6.12 (+5.15%)
PFE : 42.88 (+0.28%)
SOLY : 16.64 (+16.36%)
Soliton Confirms Conference Call to Discuss Recently Announced Significant Discovery and FDA Clearance for Today at 4:30 PM ET

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 16.64 (+16.36%)
Soliton Announces Conference Call to Discuss Recently Announced Significant Discovery and FDA Clearance

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 16.64 (+16.36%)
Thinking about buying stock in Beyond Meat, Cara Therapeutics, Eltek, Plug Power, or Soliton?

InvestorsObserver issues critical PriceWatch Alerts for BYND, CARA, ELTK, PLUG, and SOLY.

CARA : 19.84 (+2.43%)
SOLY : 16.64 (+16.36%)
Growing Global Demand for Non-Invasive Cellulite Treatment with FDA Clearance

Cellulite affects 85% to 90% of all women worldwide and was first described nearly 100 years ago, and has been the bane of women (and men) ever since. But to find a 'cure' or effective 'solution' the cause...

BSX : 40.68 (+0.64%)
SESN : 1.85 (+8.82%)
SWAV : 57.21 (-1.70%)
PFE : 42.88 (+0.28%)
SOLY : 16.64 (+16.36%)
Soliton to Initiate Pivotal Cellulite Trial after Positive Proof-of-Concept Trial Results with 20-47% Improvement in Cellulite Severity Score

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 16.64 (+16.36%)
Soliton Receives FDA 510(k) Clearance of its Acoustic Shockwave RAP Device

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 16.64 (+16.36%)
Trade SOLY with:

Business Summary

Soliton Inc. is a medical device company. Its commercial product uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of unwanted tattoos. Soliton Inc. is based in Houston, Texas.

See More

Key Turning Points

2nd Resistance Point 19.08
1st Resistance Point 17.86
Last Price 16.64
1st Support Level 14.86
2nd Support Level 13.08

See More

52-Week High 29.00
Fibonacci 61.8% 19.50
Last Price 16.64
Fibonacci 50% 16.56
Fibonacci 38.2% 13.62
52-Week Low 4.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar